Frontlight ResearchEarly access
HIV trials in Egypt
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEffect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
- Where
- Cairo
- Age
- 18 years to 65 years
- People
- 66
- Run by
- Abdelrahman Mahmoud
See details and how to joinNCT07336797